| Filed On | Filing |
|---|---|
| 13 Dec 2024 |
Form 4: Hawkins Richard J, Director
Returned 757,562 shares to the issuer · Disposed of 289,299 Stock Option (Right to Buy) (Disposition to Issuer) |
| 13 Dec 2024 |
Form 4: Zoth Lota S., Director
Returned 2,187 shares to the issuer · Disposed of 26,799 Stock Option (Right to Buy) (Disposition to Issuer) |
| 13 Dec 2024 |
Form 4: McKew John C., Chief Scientific Officer
Returned 13,153 shares to the issuer · Disposed of 241,989 Stock Option (Right to Buy) (Disposition to Issuer) |
| 13 Dec 2024 |
Form 4: Johnson Chad Allen, Director
Returned 1,076 shares to the issuer · Disposed of 25,702 Stock Option (Right to Buy) (Disposition to Issuer) |
| 13 Dec 2024 |
Form 4: van Es-Johansson An, Director
Returned 1,100 shares to the issuer · Disposed of 18,743 Stock Option (Right to Buy) (Disposition to Issuer) |
| 13 Dec 2024 |
Form 4: Raffin Thomas A., Director
Returned 9,406 shares to the issuer · Disposed of 31,914 Stock Option (Right to Buy) (Disposition to Issuer) |
| 13 Dec 2024 |
Form 4: Pitukcheewanont Pisit Duke, Chief Medical Officer
Returned 16,836 shares to the issuer · Disposed of 100,083 Stock Option (Right to Buy) (Disposition to Issuer) |
| 13 Dec 2024 |
Form 4: Lalande Kevin M., Director
Returned 731,522 shares to the issuer · Disposed of 18,698 Stock Option (Right to Buy) (Disposition to Issuer) |
| 13 Dec 2024 |
Form 4: Schuchart Aaron, Chief Business Officer
Returned 8,179 shares to the issuer · Disposed of 97,305 Stock Option (Right to Buy) (Disposition to Issuer) |
| 13 Dec 2024 |
Form 4: Powers Bradley J, General Counsel
Returned 6,334 shares to the issuer · Disposed of 83,473 Stock Option (Right to Buy) (Disposition to Issuer) |
| 13 Dec 2024 |
Form 4: Lawley Lori D, Chief Financial Officer
Returned 12,284 shares to the issuer · Disposed of 101,561 Stock Option (Right to Buy) (Disposition to Issuer) |
| 13 Dec 2024 |
Form 4: McCracken Joseph S, Director
Returned 15,721 shares to the issuer · Disposed of 18,698 Stock Option (Right to Buy) (Disposition to Issuer) |
| 06 Aug 2024 |
Form 4: McKew John C., Chief Scientific Officer
Sold 3,407 shares ($6.43K) |
| 05 Aug 2024 |
Form 4: Lawley Lori D, Chief Financial Officer
Gave up 229 shares to cover exercise price or tax ($410) |
| 05 Aug 2024 |
Form 4: McKew John C., Chief Scientific Officer
Gave up 1,593 shares to cover exercise price or tax ($2.85K) |
| 03 Jul 2024 |
Form 4: Pitukcheewanont Pisit Duke, Chief Medical Officer
Gave up 274 shares to cover exercise price or tax ($620) |
| 07 Jun 2024 |
Form 4: van Es-Johansson An, Director
Granted 3,328 Stock Option (Right to Buy) |
| 07 Jun 2024 |
Form 4: McCracken Joseph S, Director
Granted 3,328 Stock Option (Right to Buy) |
| 07 Jun 2024 |
Form 4: Johnson Chad Allen, Director
Granted 3,328 Stock Option (Right to Buy) |
| 07 Jun 2024 |
Form 4: Zoth Lota S., Director
Granted 3,328 Stock Option (Right to Buy) |
Loading...
